Position in GHRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$855,966
+$396,416 QoQ
Shares Held
31,844
-2.6% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 62 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,537,836 across 424 Biotechnology names. GHRS ranks #281 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in GHRS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $855,966 | 31,844 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $459,550 | 32,685 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $416,914 | 32,828 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $471,513 | 32,973 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $475,128 | 38,977 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $433,820 | 39,331 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $285,838 | 40,834 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $215,370 | 32,193 | Shares | Defined | 2024-11-13 | |
| 2023-12-31 | $58,800 | 10,138 | Shares | Defined | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||